Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study.
Refereed conference paper presented and published in conference proceedings

Full Text

Times Cited
Web of Science0WOS source URL

Other information
All Author(s) ListBertot LC, Gomez EV, Wong VW, Fernandez MC, Aller R, Eslam M, George J, Romero-Gomez M, Adams LA
Name of Conference68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
Start Date of Conference20/10/2017
End Date of Conference24/10/2017
Place of ConferenceWashington, DC
Country of conferenceUnited States of America
Proceedings TitleHepatology
Volume Number66
Issue NumberSuppl. 1
Pages1119A - 1119A
LanguagesEnglish-United States

Last updated on 2018-21-06 at 23:39